Hostname: page-component-77c89778f8-vpsfw Total loading time: 0 Render date: 2024-07-21T15:27:20.252Z Has data issue: false hasContentIssue false

The transcobalamin 776C>G polymorphism may be a modifiable genetic risk factor for Alzheimer's disease

Published online by Cambridge University Press:  29 June 2005

HENRIK ZETTERBERG
Affiliation:
Institutes of Clinical Neuroscience, Sahlgrenska University Hospital, Göteborg University, Sweden. Email: [email protected] Institutes of Laboratory Medicine, Sahlgrenska University Hospital, Göteborg University, Sweden. Email: [email protected] Center for Neurologic Diseases, Harvard Medical School, Boston, U.S.A.
EBBA NEXÖ
Affiliation:
Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark
LENNART MINTHON
Affiliation:
Neuropsychiatric Clinic, Malmö University Hospital, S-205 02 Malmö, Sweden
ROBERTA BOSON
Affiliation:
Neuropsychiatric Clinic, Malmö University Hospital, S-205 02 Malmö, Sweden
BJÖRN REGLAND
Affiliation:
Institutes of Clinical Neuroscience, Sahlgrenska University Hospital, Göteborg University, Sweden. Email: [email protected]
ANDREW MCCADDON
Affiliation:
University of Wales College of Medicine, General Practice, Wrexham, U.K.
K.A.J. BLENNOW
Affiliation:
Institutes of Clinical Neuroscience, Sahlgrenska University Hospital, Göteborg University, Sweden. Email: [email protected] Institutes of Laboratory Medicine, Sahlgrenska University Hospital, Göteborg University, Sweden. Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the Editor
Copyright
© International Psychogeriatric Association 2005